Evaluation of 3D-Printed Microfluidic Structures for Use in AML-Specific Biomarker Detection of PML::RARA
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020497 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Benedikt Emde und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department Hamm 1, Hamm-Lippstadt University of Applied Science, 59063 Hamm, Germany. Hauptthemen laut MEDLINE: Printing, Three-Dimensional, Oncogene Proteins, Fusion, Microfluidics, Leukemia, Promyelocytic, Acute. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Centre for Research Management (ZfF) at the University of Applied Sciences Hamm-Lippstadt as part of the “Qualification Initiative for the Promotion of You…, the Department Hamm 1 of the University of Applied Sciences Hamm-Lippstadt.
Abstract (Originalsprache)
An obstacle for many microfluidic developments is the fabrication of its structures, which is often complex, time-consuming, and expensive. Additive manufacturing can help to reduce these barriers. This study investigated whether the results of a microfluidic assay for the detection of the promyelocytic leukemia (PML)-retinoic acid receptor α (RARα) fusion protein (PML::RARA), and thus for the differential diagnosis of acute promyelocytic leukemia (APL), could be transferred from borosilicate glass microfluidic structures to additively manufactured fluidics. Digital light processing (DLP) and stereolithography (SLA) printers as well as different photopolymerizable methacrylate-based resins were tested for fabrication of the fluidics. To assess suitability, both print resolution and various physical properties, serializability, biocompatibility, and functionalization with biological molecules were analyzed. The results show that additively manufactured microfluidics are suitable for application in leukemia diagnostics. This was demonstrated by transferring the microfluidic sandwich enzyme-linked immunosorbent assay (ELISA) for PML::RARA onto the surface of magnetic microparticles from a glass structure to three-dimensional (3D)-printed parts. A comparison with conventional glass microstructures suggests lower sensitivity but highlights the potential of additive manufacturing for prototyping microfluidics. This may contribute to the wider use of microfluidics in biotechnological or medical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department Hamm 1, Hamm-Lippstadt University of Applied Science, 59063 Hamm, Germany.
- Proteome and Metabolome Research, Faculty of Biology, Bielefeld University, 33615 Bielefeld, Germany.
ORCID-Profile: Karsten Niehaus
Förderung
- the Centre for Research Management (ZfF) at the University of Applied Sciences Hamm-Lippstadt as part of the “Qualification Initiative for the Promotion of You…
- the Department Hamm 1 of the University of Applied Sciences Hamm-Lippstadt
Zitieren
APA
Emde, B., Niehaus, K., & Tickenbrock, L. (2025). Evaluation of 3D-Printed Microfluidic Structures for Use in AML-Specific Biomarker Detection of PML::RARA. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020497
Vancouver
Emde B, Niehaus K, Tickenbrock L. Evaluation of 3D-Printed Microfluidic Structures for Use in AML-Specific Biomarker Detection of PML::RARA. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020497
BibTeX
@article{Emde2025,
author = {Emde, Benedikt and Niehaus, Karsten and Tickenbrock, Lara},
title = {Evaluation of 3D-Printed Microfluidic Structures for Use in AML-Specific Biomarker Detection of PML::RARA},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020497}
}
EUVIMED